Dr. Andrea Cercek, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Expert in Colorectal Cancer
Studies Rectal Cancer
15 reported clinical trials
31 drugs studied
Area of expertise
1Colorectal Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Rectal Cancer
Stage III
Stage II
MSI-H positive
Affiliated Hospitals
Clinical Trials Andrea Cercek, MD is currently running
Tucatinib + Trastuzumab
for Rectal Cancer
This trial is testing a new treatment for people with rectal cancer. It uses two drugs, trastuzumab and tucatinib, along with standard chemotherapy. These drugs aim to block proteins that help cancer grow, while chemotherapy kills the cancer cells.
Recruiting1 award Phase 2
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
More about Andrea Cercek, MD
Clinical Trial Related4 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Andrea Cercek, MD has experience with
- Bevacizumab
- Tucatinib
- Trastuzumab
- Fluorouracil
- Oxaliplatin
- Irinotecan
Breakdown of trials Andrea Cercek, MD has run
Colorectal Cancer
Rectal Cancer
Tumors
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea Cercek, MD specialize in?
Andrea Cercek, MD focuses on Colorectal Cancer and Rectal Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Andrea Cercek, MD currently recruiting for clinical trials?
Yes, Andrea Cercek, MD is currently recruiting for 8 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Andrea Cercek, MD has studied deeply?
Yes, Andrea Cercek, MD has studied treatments such as Bevacizumab, Tucatinib, Trastuzumab.
What is the best way to schedule an appointment with Andrea Cercek, MD?
Apply for one of the trials that Andrea Cercek, MD is conducting.
What is the office address of Andrea Cercek, MD?
The office of Andrea Cercek, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.